FDA gives positive report on Impax depression drug

The Food and Drug Administration reported that a generic drug made by Impax Laboratories Inc. is safe and equivalent to the branded drug it is meant to copy.

Hayward-based Impax (OTCBB: IPXL) makes Bupropion XL 300 mg tablets as a generic version of Wellbutrin XL 300 mg tablets for treating depression. The Impax drug is marketed by Teva Pharmaceutical USA.

Impax said the drug now meets all requirements for FDA approval. Wellbutrin is a GlaxoSmithKline (NYSE: GSK) drug.

Content Continues Below